loading
Verona Pharma Plc Adr stock is traded at $63.53, with a volume of 908.58K. It is down -4.21% in the last 24 hours and up +9.60% over the past month. Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
See More
Previous Close:
$66.26
Open:
$66.51
24h Volume:
908.58K
Relative Volume:
0.65
Market Cap:
$6.15B
Revenue:
-
Net Income/Loss:
$-153.72M
P/E Ratio:
-31.77
EPS:
-2
Net Cash Flow:
$-103.81M
1W Performance:
-12.73%
1M Performance:
+9.60%
6M Performance:
+64.52%
1Y Performance:
+330.31%
1-Day Range:
Value
$62.81
$67.86
1-Week Range:
Value
$62.81
$73.60
52-Week Range:
Value
$11.39
$74.18

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
Name
Verona Pharma Plc Adr
Name
Phone
011-44-0-2032834200
Name
Address
3 MORE LONDON RIVERSIDE, LONDON
Name
Employee
209
Name
Twitter
@VeronaPharma
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
VRNA's Discussions on Twitter

Compare VRNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VRNA
Verona Pharma Plc Adr
63.46 6.15B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
431.01 128.25B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
537.01 63.70B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.25 39.07B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
252.58 33.27B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
230.75 27.58B 3.81B -644.79M -669.77M -6.24

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-28-25 Initiated TD Cowen Buy
Apr-21-25 Initiated Cantor Fitzgerald Overweight
Jan-10-25 Initiated ROTH MKM Buy
Oct-03-24 Initiated Wells Fargo Overweight
May-22-23 Resumed Jefferies Buy
Sep-19-22 Resumed Wedbush Outperform
Aug-26-22 Initiated Piper Sandler Overweight
Sep-13-21 Initiated H.C. Wainwright Buy
Aug-25-20 Initiated Jefferies Buy
Aug-10-20 Initiated Canaccord Genuity Buy
Apr-18-19 Initiated BTIG Research Buy
View All

Verona Pharma Plc Adr Stock (VRNA) Latest News

pulisher
May 08, 2025

Market Update: Verona Pharma Plc ADR (VRNA) Sees Negative Movement, Closing at 69.14 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA): An Enticing Stock To Watch - Stocksregister

May 08, 2025
pulisher
May 06, 2025

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025 - GlobeNewswire Inc.

May 06, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Verona Pharma director Vikas Sinha sells $178,416 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 - Investing.com

May 01, 2025
pulisher
May 01, 2025

Verona Pharma Plc ADR (VRNA)’s Market Momentum: Closing Strong at 72.07, Down -1.56 - DWinneX

May 01, 2025
pulisher
Apr 30, 2025

What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Verona Pharma Plc ADR [VRNA] Stock trading around $73.21 per share: What’s Next? - dbtnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

VRNA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Watch this stock’s price performance: Verona Pharma Plc ADR (NASDAQ:VRNA) - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Verona Pharma ADR earnings beat by $0.05, revenue topped estimates - Investing.com UK

Apr 29, 2025
pulisher
Apr 28, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Could Soar To Much Higher Prices In Coming Months - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 28, 2025

TD Cowen starts Verona Pharma stock at Buy, sets $100 target - Investing.com

Apr 28, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Verona Pharma Plc ADR (VRNA) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Is Astrazeneca plc ADR (AZN) positioned for future growth? - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Plc ADR [VRNA] Records 50-Day SMA of $62.73 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Tencent Music Entertainment Group ADR [TME] Officer makes an insider purchase of 1,036,363 shares worth 14.87 million. – Knox Daily - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

TAL Education Group ADR [TAL] Officer makes an insider purchase of 24,041 shares worth 0.28 million. - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Ratios Uncovered: Breaking Down Verona Pharma Plc ADR (VRNA)’s Trailing Twelve Months Metrics - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Verona Pharma Plc ADR (VRNA) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

What is the investor’s view on Marriott Vacations Worldwide Corp (VAC)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Was Phathom Pharmaceuticals Inc (PHAT)’s session last reading good? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Zentalis Pharmaceuticals Inc (ZNTL) deserves deeper analysis - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Health Report: Alamos Gold Inc (AGI)’s Ratios Tell a Tale - DWinneX

Apr 24, 2025
pulisher
Apr 21, 2025

Cantor Fitzgerald sets $80 target on Verona Pharma stock By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 17, 2025

Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit undervalued - uspostnews.com

Apr 17, 2025
pulisher
Apr 07, 2025

Verona Pharma Plc ADR [VRNA] Rickard Kathleen A. sells 79,264 Shares for $0.66 million - knoxdaily.com

Apr 07, 2025
pulisher
Apr 03, 2025

Verona Pharma Plc ADR [VRNA] Chief Medical Officer makes an insider purchase of 79,264 shares worth 0.66 million. - knoxdaily.com

Apr 03, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms - Investing.com

Mar 28, 2025
pulisher
Mar 25, 2025

The growth track for Cracker Barrel Old Country Store Inc (CBRL) has changed recently - SETE News

Mar 25, 2025
pulisher
Mar 18, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Up 298.80% This Year: What Is Going To Happen Next - Stocks Register

Mar 18, 2025
pulisher
Mar 14, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 10, 2025

Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

McEwen Mining Inc (MUX) Becoming More Attractive for Investors - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Morgan Stanley Upgrades Solaredge Technologies Inc (SEDG) to an Equal-weight from an Underweight - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Verona Pharma at Leerink Global Healthcare: Eutuvera’s Promising Launch By Investing.com - Investing.com UK

Mar 10, 2025
pulisher
Feb 28, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK

Feb 27, 2025
pulisher
Feb 21, 2025

A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily

Feb 21, 2025
pulisher
Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 - Investing.com India

Feb 12, 2025
pulisher
Feb 12, 2025

Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa

Feb 12, 2025

Verona Pharma Plc Adr Stock (VRNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$19.85
price up icon 2.11%
$65.33
price down icon 0.83%
$33.23
price up icon 0.27%
$24.65
price up icon 1.48%
$94.78
price up icon 2.13%
biotechnology ONC
$234.59
price up icon 1.01%
Cap:     |  Volume (24h):